Search results for "Heart Valve"

showing 10 items of 138 documents

The presence of infection-related antiphospholipid antibodies in infective endocarditis determines a major risk factor for embolic events.

1999

Abstract OBJECTIVES The impact of infection-associated antiphospholipid antibodies (APA) on endothelial cell activation, blood coagulation and fibrinolysis was evaluated in patients with infective endocarditis with and without major embolic events. BACKGROUND An embolic event is a common and severe complication of infective endocarditis. Despite the fact that APAs are known to be associated with infectious diseases, their pathogenic role in infective endocarditis has not been clearly defined. METHODS The relationship among the occurrence of major embolic events, echocardiographic vegetation size, endothelial cell activation, thrombin generation, fibrinolysis and APA was examined in 91 patie…

AdultMalemedicine.medical_specialtymedicine.medical_treatmentEnzyme-Linked Immunosorbent AssayGastroenterologyVon Willebrand factorRisk FactorsInternal medicinemental disordersFibrinolysisPlasminogen Activator Inhibitor 1medicineEndocarditisHumansRisk factorAgedRetrospective Studiesbiologybusiness.industryVascular diseaseFibrinolysisThrombinUltrasonography DopplerEndocarditis BacterialIntracranial Embolism and ThrombosisMiddle Agedmedicine.diseasePrognosisHeart ValvesCerebral AngiographyInfective endocarditisImmunologybiology.proteinAntibodies AntiphospholipidFemaleCardiology and Cardiovascular MedicineComplicationbusinessTomography X-Ray Computedpsychological phenomena and processesProtein CBiomarkersEchocardiography Transesophagealmedicine.drugFollow-Up StudiesProtein CJournal of the American College of Cardiology
researchProduct

Assessment of successful valve reconstruction by intraoperative transesophageal echocardiography (TEE)

1986

In 17 patients (10 patients with mitral insufficiency, 5 patients with tricuspid regurgitation, 2 patients with mitral stenosis) the result of valve reconstruction was evaluated by intraoperative two-dimensional transesophageal contrast-echocardiography (TEE). Therefore, 1–2 cc of an agitated contrast-medium (GelifundolR) were injected into the left or right ventricle. The result of reconstruction was assessed by the extent of regurgitant microbubbles into the left or right atrium. A successful valve repair could be demonstrated in 15 patients without or with only minimal regurgitation of contrast-fluid. In one patient residual severe mitral insufficiency after valve reconstruction could on…

AdultMalemedicine.medical_specialtymedicine.medical_treatmentRegurgitation (circulation)Intraoperative PeriodEsophagusValve replacementInternal medicinemedicineHumansRadiology Nuclear Medicine and imagingHeart valveCardiac imagingAgedbusiness.industryMiddle Agedmedicine.diseaseHeart ValvesSurgeryStenosismedicine.anatomical_structureEchocardiographyVentricleMitral incompetencecardiovascular systemCardiologyFemaleIntraoperative PeriodCardiology and Cardiovascular MedicinebusinessThe International Journal of Cardiac Imaging
researchProduct

Lipoprotein(a) and aortic valve stenosis: A casual or causal association?

2022

Abstract Aims This review aims to provide an update of available methods for imaging calcification activity and potential therapeutic options. Data Synthesis: Aortic valve calcification represents the most common heart valve condition requiring treatment among adults in Western societies. No medical therapies are proven to be effective in treating symptoms or reducing disease progression. Therefore, surgical or transcatheter aortic valve replacement remains the only available treatment option. Elevated circulating concentrations of lipoprotein(a) is strongly associated with degenerative aortic stenosis. This relationship was first observed in prospective observational studies, and the causa…

Adultmedicine.medical_specialtyEndocrinology Diabetes and Metabolismmedicine.medical_treatmentMedicine (miscellaneous)Settore MED/11 - Malattie dell'Apparato CardiovascolareAortic valve stenosisAortic valve calcification; Aortic valve stenosis; Drug therapy; Lipoprotein (a)Valve replacementLipoprotein (a)Internal medicinemedicineHumansProspective StudiesHeart valveNutrition and Dieteticsbiologybusiness.industryCalcinosisLipoprotein(a)medicine.diseaseObservational Studies as TopicStenosismedicine.anatomical_structureAortic ValveAortic valve stenosisAortic valve calcificationbiology.proteinCardiologyObservational studyDrug therapyAortic valve calcificationCardiology and Cardiovascular MedicinebusinessLipoprotein(a)CalcificationNutrition, Metabolism and Cardiovascular Diseases
researchProduct

Mitral valve aneurysm revealed by cross-sectional echocardiography in a patient with mitral valve prolapse

1984

We report a cerebral ischemia in a 23-year-old woman, in whom a mitral valve aneurysm with thrombotic masses was diagnosed by cross-sectional echocardiography. A prolapsing mitral leaflet was also visualized.

Adultmedicine.medical_specialtyHeart Valve DiseasesIschemiaAneurysmInternal medicineMitral valvemedicineHumansMitral valve prolapsecardiovascular diseasesCross Sectional EchocardiographyMitral Valve Prolapsebusiness.industryMitral leafletmedicine.diseaseAneurysmmedicine.anatomical_structureEchocardiographycardiovascular systemCardiologyMitral ValveFemaleCardiology and Cardiovascular MedicinebusinessComplicationInternational Journal of Cardiology
researchProduct

Cardiac manifestations of Anderson-Fabry disease in heterozygous females.

2002

AbstractObjectivesWe sought to define the prevalence of cardiac involvement in female patients with Anderson–Fabry disease (AFD).BackgroundAnderson–Fabry disease is a rare inborn X-linked lysosomal storage disorder. Globotriaosylceramide (Gb3), the major substrate of the deficient α-galactosidase A enzyme, accumulates progressively in vulnerable cells, including the cardiovascular system. It has been believed that heterozygous females have less cardiac involvement than hemizygous males with AFD.MethodsWe performed two-dimensional echocardiographic examinations of female patients heterozygous for AFD.ResultsSince 1997, a total of 55 female patients (mean age, 39.6 years; range, 6.1 to 70.8 y…

Adultmedicine.medical_specialtyPediatricsHeterozygoteendocrine system diseasesHeart diseaseAdolescentSystoleHeart Valve DiseasesDiseaseVentricular Dysfunction LeftFemale patientotorhinolaryngologic diseasesmedicinePrevalenceHumanscardiovascular diseasesProspective StudiesSystoleProspective cohort studyChildneoplasmsAgedVascular diseasebusiness.industryAge FactorsMiddle Agedmedicine.diseaseFabry diseasehumanitiesSurgeryPedigreeAnderson-Fabry DiseaseEchocardiographyFabry Diseaselipids (amino acids peptides and proteins)FemaleHypertrophy Left VentricularCardiology and Cardiovascular MedicinebusinessJournal of the American College of Cardiology
researchProduct

Comparison of hemodynamic and structural indices of ascending thoracic aortic aneurysm as predicted by 2-way FSI, CFD rigid wall simulation and patie…

2018

Patient-specific computational modeling is increasingly being used to predict structural and hemodynamic parameters, especially when current clinical tools are not accessible. Indeed, pathophysiology of ascending thoracic aortic aneurysm (ATAA) has been simulated to quantify the risk of complications by novel prognostic parameters and thus to improve the clinical decision-making process related to the intervention of ATAAs. In this study, the relevance of aneurysmal wall elasticity in determining parameters of clinical importance, such as the wall shear stress (WSS), is discussed together with the significance of applying realistic boundary conditions to consider the aortic stretch and twis…

Aortic valveAdultMalePatient-Specific Modelingmedicine.medical_specialtyComputer science0206 medical engineeringFinite Element Analysisaorti failureHeart Valve DiseasesHemodynamicsFluid-solid interaction (FSI)Health Informatics02 engineering and technology030204 cardiovascular system & hematologyComputational fluid dynamicsThoracic aortic aneurysm03 medical and health sciences0302 clinical medicineBicuspid aortic valveBicuspid Aortic Valve DiseaseInternal medicinemedicineShear stressHumansComputer SimulationAgedAortic Aneurysm ThoracicStructural mechanicsbusiness.industryFinite element analysis (FEA)Models CardiovascularMiddle Agedmedicine.diseaseAscending thoracic aortic aneurysm020601 biomedical engineeringFinite element methodElasticityComputer Science Applicationsmedicine.anatomical_structureComputational fluid-dynamic (CFD)Aortic Valvecardiovascular systemCardiologyFemaleStress Mechanicalbusiness
researchProduct

Regurgitant flow in apparently normal valve prostheses: improved detection and semiquantitative analysis by transesophageal two-dimensional color-cod…

1990

In 128 patients with apparently normally functioning prosthetic valves ( n = 136) in the aortic position ( n = 79) and the mitral position ( n = 57), the prevalence of transprosthetic regurgitant flow was studied by use of transthoracic and transesophageal two-dimensional color-coded Doppler echocardiography. With the transthoracic approach, regurgitant flow was detected in early systole or diastole for 28% of the mitral prostheses and for 29% of the aortic prostheses. With transesophageal color-coded Doppler echocardiography, regurgitant jets were visualized for 95% of the mitral prostheses and for 44% of the aortic prostheses. In 40% of the Bjork-Shiley prostheses and 88% of the St. Jude …

Aortic valveAdultMalemedicine.medical_specialtyAdolescentAortic Valve InsufficiencyDiastoleDoppler echocardiographyInternal medicineMitral valvemedicineHumansRadiology Nuclear Medicine and imagingProspective StudiesSystoleTransthoracic approachAgedmedicine.diagnostic_testbusiness.industryMiddle Agedequipment and suppliesEchocardiography DopplerRegurgitant flowProsthesis Failuremedicine.anatomical_structureAortic ValveHeart Valve Prosthesiscardiovascular systemCardiologyMitral ValveFemaleCardiology and Cardiovascular MedicinebusinessSemi quantitativecirculatory and respiratory physiologyJournal of the American Society of Echocardiography : official publication of the American Society of Echocardiography
researchProduct

Heart Valve Abnormalities in Systemic Sclerosis Patients; A Multicenter Cohort Study and Review of the Literature

2020

Background Systemic sclerosis (SSc) is a chronic autoimmune disease that is characterized by vasculopathy and fibrosis of the skin and visceral organs. Heart valve diseases are poorly described and generally not considered typical of SSc. We aimed to describe valvular abnormalities in a multicenter cohort of SSc patients and to investigate their correlation with SSc features. Methods We recruited 118 consecutive SSc patients (male/female, 14/104; mean age, 55.2 ± 12.1 years) in 3 rheumatology centers in Sicily, Italy, from January to October 2019. Results Mitral and tricuspid valve insufficiency was found in 85% and 91% of patients, respectively; regurgitations were generally mild and never…

Aortic valveAdultMalemedicine.medical_specialtyHeart Valve DiseasesTricuspid stenosisSclerodermaCohort Studies03 medical and health sciences0302 clinical medicineRheumatologyTricuspid Valve InsufficiencyMitralInternal medicineMedicineHumansMulticenter Studies as Topiccardiovascular diseases030212 general & internal medicineHeart valveAortic valveskin and connective tissue diseasesAged030203 arthritis & rheumatologyScleroderma Systemicintegumentary systembusiness.industrySystemicMitral Valve InsufficiencyMiddle Agedmedicine.diseaseValvular diseaseHeart ValvesRheumatologyTricuspid Valve InsufficiencyStenosismedicine.anatomical_structurePulmonary valvecardiovascular systemCardiologySystemic sclerosisFemalebusinessTricuspidCohort study
researchProduct

Heart valve tissue engineering: how far is the bedside from the bench?

2015

Heart disease, including valve pathologies, is the leading cause of death worldwide. Despite the progress made thanks to improving transplantation techniques, a perfect valve substitute has not yet been developed: once a diseased valve is replaced with current technologies, the newly implanted valve still needs to be changed some time in the future. This situation is particularly dramatic in the case of children and young adults, because of the necessity of valve growth during the patient's life. Our review focuses on the current status of heart valve (HV) therapy and the challenges that must be solved in the development of new approaches based on tissue engineering. Scientists and physicia…

Aortic valveHeart diseaseSwine030204 cardiovascular system & hematology0302 clinical medicineHeart valve tissue engineeringHyaluronic AcidChildProsthetic valve0303 health sciencesMARROW-DERIVED CELLSTissue ScaffoldsFetal BloodHeart Valves3. Good healthmedicine.anatomical_structureHeart Valve ProsthesisCardiologyMolecular MedicineCollagenmedicine.medical_specialtyPULMONARY VALVEBONE-MARROWInduced Pluripotent Stem CellsVENTRICULAR OUTFLOW TRACTMESENCHYMAL STEM-CELLS03 medical and health sciencesTissue scaffoldsInternal medicineEXTRACELLULAR-MATRIXmedicineAnimalsHumansHeart valveIntensive care medicineENDOTHELIAL PROGENITOR CELLSMolecular Biology030304 developmental biologyBioprosthesisAORTIC-VALVEFibrinSheepTissue Engineeringbusiness.industryEndothelial Cellsmedicine.diseaseTransplantationPulmonary valveUMBILICAL-CORD BLOOD1182 Biochemistry cell and molecular biologybusinessHUMAN AMNIOTIC-FLUIDExpert Reviews in Molecular Medicine
researchProduct

In Silico Shear and Intramural Stresses are Linked to Aortic Valve Morphology in Dilated Ascending Aorta

2017

Objective/Background: The development of ascending aortic dilatation in patients with bicuspid aortic valve (BAV) is highly variable, and this makes surgical decision strategies particularly challenging. The purpose of this study was to identify new predictors, other than the well established aortic size, that may help to stratify the risk of aortic dilatation in BAV patients.Methods: Using fluid-structure interaction analysis, both haemodynamic and structural parameters exerted on the ascending aortic wall of patients with either BAV ( n = 21) or tricuspid aortic valve (TAV; n = 13) with comparable age and aortic diameter (42.7 +/- 5.3 mm for BAV and 45.4 +/- 10.0 mm for TAV) were compared…

Aortic valveMalePatient-Specific ModelingComputed Tomography AngiographyHeart Valve DiseasesHemodynamics02 engineering and technology030204 cardiovascular system & hematology0302 clinical medicineBicuspid aortic valveBicuspid Aortic Valve DiseaseRisk FactorsAortaSinotubular JunctionModels CardiovascularSettore ING-IND/34 - Bioingegneria IndustrialeComputational modelingAneurysm of ascending aortaMiddle AgedAortic AneurysmHeart Valve Diseasemedicine.anatomical_structureAortic Valvecardiovascular systemCardiologyWall shear streFemaleCardiology and Cardiovascular MedicineBlood Flow VelocityDilatation PathologicHumanmedicine.medical_specialtyBicuspid aortic valve0206 medical engineeringAortography03 medical and health sciencesInternal medicinemedicine.arteryAscending aortamedicineHumansAgedAortabusiness.industryRisk FactorSignificant differenceHemodynamicsmedicine.disease020601 biomedical engineeringAortic wallRegional Blood FlowSurgeryStress Mechanicalbusiness
researchProduct